RESUMEN
Systemic inflammation or insulin resistance drive atherosclerosis. However, they are difficult to capture for assessing cardiovascular risk in clinical settings. The monocyte-to-high-density lipoprotein ratio (MHR) is an accessible biomarker that integrates inflammatory and metabolic information and has been associated with poorer cardiovascular outcomes. Our aim was to evaluate the association of MHR with the presence of subclinical atherosclerosis in patients with psoriasis. The study involved a European and an American cohort including 405 patients with the disease. Subclinical atherosclerosis was assessed by coronary computed tomography angiography. First, MHR correlated with insulin resistance through homeostatic model assessment for insulin resistance, with high-sensitivity CRP and with 18F-fluorodeoxyglucose uptake in spleen, liver, and bone marrow by positron emission tomography/computed tomography. MHR was associated with both the presence of coronary plaques >50% of the artery lumen and noncalcified coronary burden, beyond traditional cardiovascular risk factors (P < .05). In a noncalcified coronary burden prediction model accounting for cardiovascular risk factors, statins, and biologic treatment, MHR added value (area under the curve base model = 0.72 vs area under the curve base model plus MHR = 0.76, P = .04) within the American cohort. These results suggests that MHR may detect patients with psoriasis who have subclinical burden of cardiovascular disease and warrant more aggressive measures to reduce lifetime adverse cardiovascular outcomes.
RESUMEN
Psoriasis is a chronic and inflammatory disease that affects the skin and joints and is associated with multiple comorbidities and cardiovascular risk factors. Consequently, patients with psoriasis have an increased risk of cardiovascular diseases such as atherosclerosis, a chronic pathology that shares common inflammatory and immune-response mechanisms with psoriasis, including vascular inflammation and complement activation. To better understand the relationship between atherosclerosis and psoriasis, a proteomics study followed by a bioinformatics analysis was carried out, with a subsequent validation step using ELISA and western blotting. When the plasma from patients with psoriasis alone was compared with that from patients with psoriasis and atherosclerosis, 31 proteins of interest related to the complement system and oxygen transport were identified. After the validation phase, 11 proteins appeared to define the presence of subclinical atherosclerosis in patients with psoriasis, indicating the importance of complement cascades in the development of atherosclerotic plaques in individuals with psoriasis. These results are a step forward in understanding the pathological pathways implicated in the cardiovascular risk associated with this population, which may represent an interesting starting point for developing predictive tools that improve the follow-up of these patients and design more effective therapies.
RESUMEN
BACKGROUND AND OBJECTIVES: Melanoma differentiation-associated gene 5 antibody (anti-MDA5) in dermatomyositis (DM) is associated with rapidly progressive interstitial lung disease and poor prognosis. Early diagnosis is key to improving the prognosis of these patients. The aim was to confirm cutaneous characteristics in patients with anti-MDA5 dermatomyositis and to explore new diagnostic markers for the presence of anti-MDA5 (anti-MDA5+ ). PATIENTS AND METHODS: A multicenter cross-sectional retrospective cohort study of 124 patients diagnosed with DM, of which 37 were anti-MDA5+ . Demographic data, laboratory data, and clinical manifestations were collected. RESULTS: Anti-MDA5+ DM is characterized by a distinct mucocutaneous phenotype that includes oral lesions, alopecia, mechanic's hands, palmar and dorsal papules, palmar erythema, vasculopathy, and skin ulceration. We found vasculopathy and digit tip involvement very frequently in anti-MDA5+ patients (p <0.001), being a diagnostic marker of anti-MDA5+ (OR, 12.355; 95% CI 2.850-79.263; p = 0.012 and OR, 7.447; 95% CI 2.103-46.718; p = 0.004, respectively). The presence of ulcers deserves special mention, especially in anti-MDA5+ patients, because in our cohort, up to 97% of the anti-MDA5+ patients had ulcers. CONCLUSIONS: In patients with suspected DM with digit tip involvement or vasculopathy, the presence of anti-MDA5 antibodies must be ruled out, as it may be a clinical predictor.
Asunto(s)
Dermatomiositis , Humanos , Estudios Retrospectivos , Helicasa Inducida por Interferón IFIH1 , Úlcera , Estudios Transversales , Autoanticuerpos , PronósticoAsunto(s)
Úlcera del Pie/etiología , Pigmentos Biológicos/análisis , Infecciones por Pseudomonas/etiología , Pseudomonas aeruginosa/aislamiento & purificación , Ácido Acético/uso terapéutico , Antibacterianos/uso terapéutico , Ciprofloxacina/uso terapéutico , Terapia Combinada , Dermoscopía , Femenino , Fluorescencia , Úlcera del Pie/tratamiento farmacológico , Úlcera del Pie/metabolismo , Úlcera del Pie/terapia , Humanos , Inmersión , Levofloxacino/uso terapéutico , Persona de Mediana Edad , Infecciones por Pseudomonas/tratamiento farmacológico , Infecciones por Pseudomonas/metabolismo , Infecciones por Pseudomonas/terapia , Pseudomonas aeruginosa/químicaRESUMEN
BACKGROUND: Although subclinical enthesopathy is a well-established diagnostic criterion for psoriatic arthritis (PsA), it is frequently overlooked, as many patients are asymptomatic. The possibility of finding a clinical clue predicting enthesopathy would help clinicians establish an early diagnosis of PsA. MATERIAL AND METHODS: A prospective single-center study of a total of 90 patients with psoriasis was conducted to assess the presence of entheseal abnormalities as detected by ultrasound, and to determine any correlation with nail involvement. RESULTS: Entheseal abnormalities were found in 23 patients (25.5 %), 19 (82.6 %) of whom showed nail involvement, whereas four (17.4 %) individuals did not. Enthesopathy was present in 31.1 % (19/61) of patients with onychopathy compared to 13.8 % (4/29) of those without nail involvement (p = 0.07). There was a significant correlation between target NAPSI score and evidence of enthesopathy. In addition, the number of nails affected also showed a significant correlation with the presence of enthesopathy (p = 0.035). CONCLUSIONS: Clinical evidence of onychopathy may be the clue to an early diagnosis of enthesopathy in psoriasis patients.
Asunto(s)
Entesopatía/diagnóstico por imagen , Entesopatía/epidemiología , Enfermedades de la Uña/diagnóstico , Enfermedades de la Uña/epidemiología , Psoriasis/diagnóstico , Psoriasis/epidemiología , Distribución por Edad , Comorbilidad , Diagnóstico Precoz , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Pronóstico , Reproducibilidad de los Resultados , Medición de Riesgo/métodos , Factores de Riesgo , Sensibilidad y Especificidad , Distribución por Sexo , España/epidemiologíaRESUMEN
HINTERGRUND: Obwohl subklinische Enthesiopathie ein gut etabliertes diagnostisches Merkmal der Psoriasisarthritis (PsA) ist, wird sie häufig übersehen, da viele Patienten asymptomatisch sind. Gäbe es klinische Hinweise auf das Vorliegen einer Enthesiopathie, würde dies den Klinikern die Möglichkeit eröffnen, eine PsA frühzeitig zu diagnostizieren. MATERIAL UND METHODEN: Es wurde eine monozentrische prospektive Studie mit insgesamt 90 Psoriasis-Patienten durchgeführt, um mittels Ultraschall das Vorliegen von Enthesenanomalien zu untersuchen und eine Korrelation mit dem Befall der Nägel festzustellen. ERGEBNISSE: Enthesenanomalien wurden bei 23 Patienten (25,5 %) gefunden, von denen 19 (82,6 %) Nagelbefall aufwiesen. Bei 4 Patienten waren die Nägel nicht betroffen. Enthesiopathie lag bei 31,1 % (19/61) der Patienten mit Onychopathie vor, von den Patienten ohne Nagelbefall litten nur 13,8 % (4/29) an Enthesiopathie (p = 0,07). Zwischen dem Target-NAPSI-Score und dem Vorliegen einer Enthesiopathie bestand eine signifikante Korrelation. Eine signifikante Korrelation bestand darüber hinaus auch zwischen dem Vorliegen einer Enthesiopathie und der Anzahl der betroffenen Nägel (p = 0,035). SCHLUSSFOLGERUNGEN: Klinische Belege für eine Onychopathie können der Schlüssel für die frühe Diagnose einer Enthesiopathie bei Psoriasis-Patienten sein.
RESUMEN
Sarcoidosis is an idiopathic multisystem granulomatous disease that commonly involves the skin in 25% of affected patients. Because lesions assume a vast array of morphologies, a classification dividing them into specific (with presence of typical granulomas in the biopsy) or nonspecific (not containing granulomas) has been proposed. In the first group the variant morpheaform is considered exceptional. We review the cases reported in the literature and describe the possible differential diagnosis. We highlight the importance of recognizing the very atypical presentation of sarcoidosis and its ability to mimic morpheaform or sclerosis diseases in our patients.
Asunto(s)
Sarcoidosis/diagnóstico , Enfermedades de la Piel/diagnóstico , Diagnóstico Diferencial , Granuloma/diagnóstico , Granuloma/patología , Humanos , Sarcoidosis/patología , Esclerosis , Enfermedades de la Piel/patologíaRESUMEN
Since Perrinaud in 2006 first described three patients with hemorrhagic bullae in relation to the use of heparins, numerous cases have been published. Currently, this entity has been established as a clearly defined pathology. We review all reported cases, diagnostic features and features that differentiate it from other skin manifestations caused by heparin having a worse prognosis and requiring a precise identification.
Asunto(s)
Anticoagulantes/efectos adversos , Erupciones por Medicamentos/etiología , Heparina/efectos adversos , Enfermedades Cutáneas Vesiculoampollosas/inducido químicamente , Diagnóstico Diferencial , Erupciones por Medicamentos/diagnóstico , Erupciones por Medicamentos/patología , Erupciones por Medicamentos/terapia , Humanos , Enfermedades Cutáneas Vesiculoampollosas/diagnóstico , Enfermedades Cutáneas Vesiculoampollosas/patología , Enfermedades Cutáneas Vesiculoampollosas/terapiaAsunto(s)
Enfermedades de los Genitales Femeninos/diagnóstico , Hiperpigmentación/diagnóstico , Enfermedades Cutáneas Genéticas/diagnóstico , Enfermedades Cutáneas Papuloescamosas/diagnóstico , Adulto , Biopsia , Diagnóstico Diferencial , Salud de la Familia , Femenino , Enfermedades de los Genitales Femeninos/patología , Humanos , Hiperpigmentación/genética , Hiperpigmentación/patología , Síndrome de Peutz-Jeghers/diagnóstico , Piel/patología , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Genéticas/patología , Enfermedades Cutáneas Papuloescamosas/genética , Enfermedades Cutáneas Papuloescamosas/patologíaAsunto(s)
Anemia Mielopática/etiología , Examen de la Médula Ósea , Melanoma/secundario , Células Madre Neoplásicas/patología , Proteínas S100/análisis , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biomarcadores de Tumor , Biopsia con Aguja , Resultado Fatal , Humanos , Neoplasias Hepáticas/diagnóstico por imagen , Neoplasias Hepáticas/secundario , Masculino , Melanoma/sangre , Melanoma/complicaciones , Melanoma/diagnóstico por imagen , Melanoma/tratamiento farmacológico , Células Madre Neoplásicas/química , Neoplasias del Bazo/diagnóstico por imagen , Neoplasias del Bazo/secundario , Tomografía Computarizada por Rayos XRESUMEN
Eosinophilic fasciitis (EF) is a rare entity characterized by symmetrical and painful thickness and induration of the skin, especially localized on forearms and thorax and generally accompanied by eosinophilia. Although several reports indicate the relationship between EF and hematological disorders such as aplastic anemia, polycythemia vera, or myelomonocytic leukemia, the association with lymphomas is extremely rare. Only a few cases of EF have been previously described preceding or concomitant to the Hodgkin disease, peripheral T-cell lymphoma, B-cell lymphoma, and mycosis fungoides. We report for the first time a 76-year-old man with an EF associated with a peripheral T-cell lymphoma not otherwise specified. We review the relationship between both conditions. In conclusion, we present a unique case of EF as a manifestation of a T-cell lymphoma not otherwise specified. The present case demonstrates the importance of clinical and radiological studies in those cases of EF to rule out a visceral, lymph node, or cutaneous lymphoma.
Asunto(s)
Eosinofilia/diagnóstico , Fascitis/diagnóstico , Linfoma Cutáneo de Células T/diagnóstico , Síndromes Paraneoplásicos/diagnóstico , Neoplasias Cutáneas/diagnóstico , Piel/patología , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biomarcadores de Tumor/análisis , Biopsia , Eosinofilia/inmunología , Eosinofilia/patología , Fascitis/inmunología , Fascitis/patología , Humanos , Inmunohistoquímica , Linfoma Cutáneo de Células T/tratamiento farmacológico , Linfoma Cutáneo de Células T/inmunología , Linfoma Cutáneo de Células T/patología , Masculino , Síndromes Paraneoplásicos/inmunología , Síndromes Paraneoplásicos/patología , Valor Predictivo de las Pruebas , Piel/inmunología , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/inmunología , Neoplasias Cutáneas/patología , Resultado del TratamientoAsunto(s)
Absidia/aislamiento & purificación , Leucemia Linfocítica Crónica de Células B/complicaciones , Mucormicosis/etiología , Anciano de 80 o más Años , Anfotericina B/uso terapéutico , Anemia Hemolítica Autoinmune/complicaciones , Anemia Hemolítica Autoinmune/tratamiento farmacológico , Anticuerpos Monoclonales de Origen Murino/efectos adversos , Anticuerpos Monoclonales de Origen Murino/uso terapéutico , Antifúngicos/uso terapéutico , Terapia Combinada , Crioglobulinemia/tratamiento farmacológico , Crioglobulinemia/etiología , Ciclofosfamida/efectos adversos , Ciclofosfamida/uso terapéutico , Desbridamiento , Dexametasona/efectos adversos , Dexametasona/uso terapéutico , Resultado Fatal , Femenino , Humanos , Huésped Inmunocomprometido , Inmunosupresores/efectos adversos , Inmunosupresores/uso terapéutico , Liposomas , Mucormicosis/tratamiento farmacológico , Mucormicosis/microbiología , Mucormicosis/patología , Mucormicosis/cirugía , Púrpura Trombocitopénica Idiopática/complicaciones , Púrpura Trombocitopénica Idiopática/tratamiento farmacológico , RituximabRESUMEN
Se realizó un estudio descriptivo y transversal de 32 alumnas de primer año de enfermería, seleccionadas al azar de 85 integrantes del curso para trabajadores en la Facultad de Enfermería, perteneciente a la Universidad de Ciencias Médicas de Santiago de Cuba, durante los meses de noviembre y diciembre de 2011, previa solicitud de su consentimiento por escrito para participar en la investigación. Las variables analizadas para ello fueron: edades, personas causantes de la violencia, tipos de violencia y autoestima. Entre los principales resultados sobresalió la primacía del jefe inmediato superior como perpetrador de los comportamientos agresivos, del maltrato verbal como modalidad utilizada para la ofensa y de la autoestima baja. Se halló también que ese problema biopsicosocial afecta aún a numerosas mujeres en Cuba y el mundo, por lo cual se requieren acciones mancomunadas de diversos sectores de la sociedad y de la propia fémina maltratada para disminuir o eliminar su ocurrencia.
A descriptive cross-sectional study was carried out in 32 first year-students of nursing, randomly selected from 85 members of the course for workers at the Faculty of Nursing, belonging to the Medical University of Santiago de Cuba, during November and December 2011, on request of their written consent to participate in the research. The variables for this were age, people using violence, types of violence and self-esteem. Among the main results were the primacy of immediate superior as a perpetrator of aggressive behaviors, verbal abuse as modality used for insult and low self-esteem. It was also found that this biopsychosocial problem still affects many women in Cuba and in the world, which will require joint actions of different sectors of the society and of the battered woman to reduce or eliminate its occurrence.